Ascendis Pharma A/SASND
13F holders, Q2 2026 (June 30)10holders −256
2new positions
49sold out
$266.72avg. 13F price*
At the end of Q2 2026, 10 institutions reported holding Ascendis Pharma A/S (ASND) in their 13F filings, down 256 from Q1 2026. 2 opened new positions and 49 sold out. The largest holders were Frazier Life Sciences Management, L.P. ($60.1M), Neuberger Berman Group LLC ($38.1M) and Oddo BHF Asset Management Sas ($34.3M).
- Company
- Ascendis Pharma A/S
- CUSIP
- 04351P101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $49.0M |
| Exits | 49 | $387.5M |
All 13F filers, Q1 2026 → Q2 2026: 275,398 shares bought and 1,703,002 shares sold, net −1,427,604 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Frazier Life Sciences Management, L.P. | 1.31% | Add +68.9% | 225,155 | $60.1M |
| Neuberger Berman Group LLC | 0.03% | New | 142,705 | $38.1M |
| Oddo BHF Asset Management Sas | 1.60% | No change | 128,657 | $34.3M |
| Quadrature Capital Ltd | 0.09% | New | 40,845 | $10.9M |
| Ferguson Wellman Capital Management, Inc. | 0.01% | No change | 2,600 | $693K |
| Dearborn Partners LLC | 0.02% | No change | 1,300 | $347K |
| E Fund Management (Hong Kong) Co., Ltd. | 0.01% | Add +40.0% | 84 | $22K |
| Ninepoint Partners LP | 0.00% | Reduce -99.5% | 26 | $7K |
| IFP Advisors, Inc | 0.00% | Add +16.7% | 14 | $3K |
| Huntington National Bank | 0.00% | No change | 1 | $244 |
"% of holder's portfolio" is ASND's weight in each manager's 13F, not the share of Ascendis Pharma A/S the manager owns.